1. Home
  2. Labeler Index
  3. A-s Medication Solutions
  4. 50090-2795
  5. Product Images: Divalproex Sodium

Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 50090-2795 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - divalproex fig1

Figure 1 - divalproex fig1

Figure 2 - divalproex fig2

Figure 2 - divalproex fig2

Figure 3 - divalproex fig3

Figure 3 - divalproex fig3

This appears to be a graph showing the % Reduction in CPS (Central Processing Unit) rate in high dose and low dose, with the number of patients on the y-axis and the level of improvement on the x-axis.*

Figure 4 - divalproex fig4

Figure 4 - divalproex fig4

This is a figure displaying the mean 4-week migraine rates for two studies comparing the use of a placebo versus delayed-release tablets of divalproex sodium for migraine treatment. The mean dose of divalproex sodium delayed-release tablets for study 1 was 1,087 mg/day, while for study 2, the dose ranged from 500 to 1,000 mg/day.*

Chemical Structure - divalproex str

Chemical Structure - divalproex str

Label Image - lbl500902795

Label Image - lbl500902795

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.